Expertise in
1
conditions

Mansi L. Sharma

New Delhi, DL, IN 
Expertise in
1
conditions
New Delhi, DL, IN 

Overview

Mansi Sharma practices practicing medicine in New Delhi, India.

Ms. Sharma is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Tuberculous Uveitis.

She is actively involved in clinical research, co-authoring 61 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

New Delhi, DL, India
Other Locations
Ropar, PB, India
Delhi, DL, India
Rohini, MP, India
Jamnagar, JK, India
Ropar, BR, India
Bhubaneshwar, OR 751024, India
Patiala, HP, India
Bengaluru, KA, India
Noida, UP 201301, India
Gandhi, UP 110085, India
Chandigarh, CH, India
Mangalore, KA, India
Shimla, HP, India
Mathura, WB, India
Udaipur, HP, India
Indore, MP, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: March 04, 2026
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 3

61 Total Publications

SPRTN preserves RNA polymerase I transcription under genotoxic drug stress in lung adenocarcinoma.
SPRTN preserves RNA polymerase I transcription under genotoxic drug stress in lung adenocarcinoma.
Journal: Frontiers in oncology
Published: June 23, 2026

Frequently Asked Questions about Mansi L. Sharma

Is Mansi L. Sharma a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Mansi L. Sharma is classified as an Advanced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mansi L. Sharma participate in research or clinical trials?

Yes. Mansi L. Sharma has published 61 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Mansi L. Sharma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sharma's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile